Plerixafor in Acute Respiratory Distress Syndrome Related to COVID-19 (Phase IIb)

NCT05411575 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped No participants Enrolled

Conditions

COVID-19 Acute Respiratory Distress Syndrome
COVID-19

Interventions

DRUG: Plerixafor 20 MG/ML [Mozobil]
OTHER: Placebo

Sponsor

4Living Biotech